Disposable catheter breakthrough, a world firstFebruary 06, 2006A unique low cost disposable solid-state catheter that can measure swallowing pressure has been developed by a University of South Australia research team using intelligent manufacturing processes that eliminate the infection risks posed by existing catheters. Believed to be the first of its kind in the world, the catheter is one of the new products being developed in the emerging field of bio micro-electro-mechanical systems, or BioMEMS, which have applications in the biomedical field. The new catheter has many advantages over existing catheters, according to UniSA research fellow Dr Hung-Yao Hsu, who is developing the catheter with industry partner, the Women's and Children's Hospital (WCH). "Current catheters rely on the transmission of pressure via water filled lumina to transducers external to the body. Each lumen is like a garden hose with water running through. If the outlet of the hose is blocked suddenly, the pressure inside will build up and generate a pressure wave back to the tap end of the hose where it can then be sensed. The working principle behind the existing water perfusion catheter is the same as the watering hose. Because fluid is always flowing, patients sometimes feel uncomfortable and turn their bodies over, which increases the risk of inhaling fluid into their airway," Dr Hsu said. "Existing catheters also need to be recalibrated before each use, but posture changes, movement and fluctuation in the flow rate can cause variations in pressure, which mean that the accuracy of measurement cannot be guaranteed. In addition, dampening of the pressure signal leads to under-recording of peak swallowing pressures, so rapid pressure changes are not be picked up instantaneously and the signal may be missed, which could result in a wrong diagnosis being made. "Another significant disadvantage of the catheters is that they are expensive and are often reused to cut medical costs. This carries a risk of transmitting disease between patients," Dr Hsu said. "The new catheter uses solid-state sensors to measure the pressure of swallowing and eliminate the risk of fluid getting into the airway. These sensors are very responsive to pressure changes and give accurate, high resolution real-time readings. And while most catheters on the market only measure pressure, the new catheter is multifunctional, capable of recording a range of measurements," Dr Hsu said. "In addition, it is estimated that the new catheter will be about ten times cheaper than current models, and is designed for single use only, eliminating the risks associated with reuse." Dr Hsu said that after more than two years of hard work and dedication, the catheter has passed the validation of a major milestone, with the design concept being verified through rigorous tests in laboratories and in-vivo tests on humans. Working with Dr Hsu were Dr Taher Omari and his team at WCH, who provided the catheter specifications and medical consultancy to help with the design of the disposable catheter and conducted in-progress tests and the final in-vivo tests to verify the design. Sensor samples for this research were provided free of charge from The Silicon Microstructures Inc in California, USA. The catheter project is moving towards commercialisation and Dr Hsu expects the first disposable catheter to be launched in two years' time. "The new catheter will have important outcomes for improved health and comfort of patients, as well as significant savings in the cost of health care, both nationally and internationally,\\\ Research Australia |
|||||||||||||||||||||
| Related Catheter Current Events and Catheter News Articles Brain injured athletes may benefit from hypothermia research NFL players and other athletes who suffer serious or multiple concussions may benefit from ground-breaking research being conducted by scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center. The scientists are developing a surgical technique that involves hypothermia in specific regions of the brain. When seconds count: Interventional radiology treatment for pulmonary embolism saves lives Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology. Stanford study recommends change in treating pulmonary embolisms William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics. Major improvements made in engineering heart repair patches from stem cells University of Washington (UW) researchers have succeeded in engineering human tissue patches free of some problems that have stymied stem-cell repair for damaged hearts. Michigan hospital launches gene therapy study for Parkinson's disease A Michigan hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer. Study of DuraPrep versus chlorhexidine 3M Health Care today announced the publication of a new independent study "Effects of Preoperative Skin Preparation on Postoperative Wound Infection Rates: A Prospective Study of 3 Skin Preparation Protocols," that compared the effects of three different skin preparation solutions on surgical-site infections. A Thermometer for the Earth According to climate change experts, our planet has a fever - melting glaciers are just one stark sign of the radical changes we can expect. Calcium scans may be effective screening tool for heart disease A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death. New type of sirolimus-eluting stent demonstrates superior results A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with greater vessel wall integrity surrounding the stent, confirming the finding of superiority of the SES over the PES stent for the trial's primary endpoint of in-stent late loss. Mount Sinai first in nation to ablate atrial fibrillation using new visually-guided balloon catheter Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter. More Catheter Current Events and Catheter News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||